Alpha-adrenergic Stimulation Mediates Glucose Uptake Through Phosphatidylinositol 3-kinase in Rat Heart
Overview
Authors
Affiliations
We examined whether insulin and catecholamines share common pathways for their stimulating effects on glucose uptake. We perfused isolated working rat hearts with Krebs-Henseleit buffer containing [2-3H]glucose (5 mmol/L, 0.05 microCi/mL) and sodium oleate (0.4 mmol/L). In the absence or presence of the phosphatidylinositol 3-kinase (PI3-K) inhibitor wortmannin (3 micromol/L), we added insulin (1 mU/mL), epinephrine (1 micromol/L), phenylephrine (100 micromol/L) plus propranolol (10 micromol/L, selective alpha-adrenergic stimulation), or isoproterenol (1 micromol/L) plus phentolamine (10 micromol/L, selective beta-adrenergic stimulation) to the perfusate. Cardiac power was found to be stable in all groups (between 8.07+/-0.68 and 10.7+/-0. 88 mW) and increased (25% to 47%) with addition of epinephrine, but not with selective alpha- and beta-adrenergic stimulation. Insulin and epinephrine, as well as selective alpha- and beta-receptor stimulation, increased glucose uptake (the following values are in micromol/[min. g dry weight]: basal, 1.19+/-0.13; insulin, 3.89+/-0.36; epinephrine, 3.46+/-0.27; alpha-stimulation, 4.08+/-0.40; and beta-stimulation, 3.72+/-0.34). Wortmannin completely inhibited insulin-stimulated and selective alpha-stimulated glucose uptake, but it did not affect the epinephrine-stimulated or selective beta-stimulated glucose uptake. Sequential addition of insulin and epinephrine or insulin and alpha-selective stimulation showed additive effects on glucose uptake in both cases. Wortmannin further blocked the effects of insulin on glycogen synthesis. We conclude that alpha-adrenergic stimulation mediates glucose uptake in rat heart through a PI3-K-dependent pathway. However, the additive effects of alpha-adrenergic stimulation and insulin suggest 2 different isoforms of PI3-K, compartmentation of PI3-K, potentiation, or inhibition by wortmannin of another intermediate of the alpha-adrenergic signaling cascade. The stimulating effects of both the alpha- and the beta-adrenergic pathways on glucose uptake are independent of changes in cardiac performance.
Paulussen F, Kulkarni C, Stolz F, Lescrinier E, De Graeve S, Lambin S Front Cell Dev Biol. 2023; 10:1041930.
PMID: 36699012 PMC: 9869975. DOI: 10.3389/fcell.2022.1041930.
Perez D Front Cell Dev Biol. 2021; 9:652152.
PMID: 34113612 PMC: 8185284. DOI: 10.3389/fcell.2021.652152.
Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.
Perez D Int J Mol Sci. 2021; 22(11).
PMID: 34071350 PMC: 8198887. DOI: 10.3390/ijms22115783.
Glucose transporters in cardiovascular system in health and disease.
Bertrand L, Auquier J, Renguet E, Ange M, Cumps J, Horman S Pflugers Arch. 2020; 472(9):1385-1399.
PMID: 32809061 DOI: 10.1007/s00424-020-02444-8.
Shi T, Papay R, Perez D J Recept Signal Transduct Res. 2016; 37(2):124-132.
PMID: 27277698 PMC: 7788357. DOI: 10.1080/10799893.2016.1193522.